2021 BRN Discussion, page-27659

What Ken Scarince is speaking too is the delivery of the AKIDA technology as a commercial product to market.

Brainchip has done this they are first to market. They sell IP and AKIDA chips and modules including Raspberry Pi and you can buy them yesterday.

They do not build Covid-19 detectors, electric vehicles, drones or space ships OR ANY OTHER CONSUMER PRODUCT.

Brainchip is developing next generation AKIDA technology and they are racing to bring that IP, AKIDA chips and modules to market. They have a roadmap published through to AKIDA4000 this is what they are chasing.

As for ResApp even if they were a competitor they are a competitor for NaNose and NaNose is way out in front on what it has reported. The trials being run by ResApp are to collect data to try and use to build an app that could possibly ID Covid-19.

NaNose did those trials in 2020 in Wuhan and Brainchip and NaNose proved that the NaNose sensor using AKD1000 could identify Covid-19 with 95% accuracy. NaNose is presently conducting FDA trials to have their device approved. ResApp has nothing to approve yet and may fail.

My opinion only DYOR
FF

AKIDA BALLISTA